PIACENTE F.

The Primary Open-Angle Glaucoma (POAG) is a neurodegenerative disease and its clinical out-comes lead to visual field constriction and blindness. The POAG etiology is very complex and its pathogenesis is mainly explained through both mechanical and vascular theories. The trabecular meshwork (TM), the most sensitive tissue of the eye anterior...

The present study has evaluated the effects of dietary partially-defatted black soldier fly (BSF; Hermetia illucens L.) larva meal on the blood parameters, antioxidant status, and histological features of the organs of broiler ducks. A total of 192 female 3-days of age Muscovy ducklings (Cairina moschata domestica) were divided into four...

Cancer cells are highly dependent on Nicotinamide phosphoribosyltransferase (NAMPT) activity for prolifera-tion, therefore NAMPT represents an interesting target for the development of anti-cancer drugs. Several com-pounds, such as FK866 and CHS828, were identified as potent NAMPT inhibitors with strong anti-cancer activity, although none of...

Targeting cancer cells that are highly dependent on the nicotinamide adenine dinucleotide (NAD+) metabolite is a promising therapeutic strategy. Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme catalyzing NAD+ production. Despite the high efficacy of several developed NAMPT inhibitors (i.e., FK866 (APO866)) in...

APO866 is a small molecule drug that specifically inhibits nicotinamide phosphoribosyltransferase (NAMPT), a key enzyme involved in nicotinamide adenine dinucleotide (NAD) biosynthesis from the natural precursor nicotinamide. Although, the antitumor activity of APO866 on various types of cancer models has been reported, information regarding...

Approximately 75% of all breast cancers express the oestrogen and/or progesterone receptors. Endocrine therapy is usually effective in these hormone-receptor-positive tumours, but primary and acquired resistance limits its long-term benefit1,2. Here we show that in mouse models of hormone-receptor-positive breast cancer, periodic fasting or a...

Approximately 75% of all breast cancers express the oestrogen and/or progesterone receptors. Endocrine therapy is usually effective in these hormone-receptor-positive tumours, but primary and acquired resistance limits its long-term benefit1,2. Here we show that in mouse models of hormone-receptor-positive breast cancer, periodic fasting or a...